Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD3470 in MTAP-deficient advanced or metastatic non-squamous NSCLC
CTR20262649Phase 2Active
- Sponsor
- AstraZeneca
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AZD3470 in non-small cell lung cancer (NSCLC), bronchial carcinoma, sponsored by AstraZeneca. Started Jul 2026; status: active.
02
Drugs
AZD3470
03
Conditions
non-small cell lung cancer (NSCLC)bronchial carcinoma
Beyond the preview
Go deeper on CTR20262649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262649.